multiple myeloma

Poseida Therapeutics demonstrated that their new CAR T-cell treatment for multiple myeloma — P-BCMA-101 — possessed features that make it stand out in the field of gene-edited cancer cell ... Read more

July 7, 2017July 7, 2017

FDA Suspends Keytruda Combination Trials for Myeloma After Patient Deaths

multiple myeloma, News

The U.S. Food and Drug Administration (FDA) has ordered Merck to suspend two Phase 3 and part of a Phase 1 clinical trials in which Keytruda (pembrolizumab) is tested in combination ... Read more

June 14, 2017

BMT Program at MedStar Georgetown Completes 100th Blood Stem Cell Transplant

multiple myeloma, News

John Theurer Cancer Center and MedStar Georgetown University Hospital have announced the completion of the 100th blood stem cell transplant since its joint Bone Marrow Transplant (BMT) Program treated ... Read more